US20090051870A1 - Presbyopic treatment system - Google Patents

Presbyopic treatment system Download PDF

Info

Publication number
US20090051870A1
US20090051870A1 US12/229,125 US22912508A US2009051870A1 US 20090051870 A1 US20090051870 A1 US 20090051870A1 US 22912508 A US22912508 A US 22912508A US 2009051870 A1 US2009051870 A1 US 2009051870A1
Authority
US
United States
Prior art keywords
lens
optical zone
diopters
power
power profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/229,125
Other languages
English (en)
Inventor
Joseph Michael Lindacher
Shyamant Ramana Sastry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40032824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20090051870(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to US12/229,125 priority Critical patent/US20090051870A1/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LINDACHER, JOSEPH MICHAEL, SASTRY, SHYAMANT RAMANA
Publication of US20090051870A1 publication Critical patent/US20090051870A1/en
Priority to US13/162,182 priority patent/US8672474B2/en
Priority to US14/167,648 priority patent/US9039172B2/en
Priority to US14/693,303 priority patent/US9557579B2/en
Priority to US15/385,992 priority patent/US20170102556A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/041—Contact lenses for the eyes bifocal; multifocal
    • G02C7/044—Annular configuration, e.g. pupil tuned
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/024—Methods of designing ophthalmic lenses
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/024—Methods of designing ophthalmic lenses
    • G02C7/027—Methods of designing ophthalmic lenses considering wearer's parameters
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/024—Methods of designing ophthalmic lenses
    • G02C7/028—Special mathematical design techniques
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/041—Contact lenses for the eyes bifocal; multifocal
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/041—Contact lenses for the eyes bifocal; multifocal
    • G02C7/042—Simultaneous type
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/047—Contact lens fitting; Contact lenses for orthokeratology; Contact lenses for specially shaped corneae
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/06—Lenses; Lens systems ; Methods of designing lenses bifocal; multifocal ; progressive
    • G02C7/061—Spectacle lenses with progressively varying focal power
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/06—Lenses; Lens systems ; Methods of designing lenses bifocal; multifocal ; progressive
    • G02C7/061—Spectacle lenses with progressively varying focal power
    • G02C7/063—Shape of the progressive surface
    • G02C7/066—Shape, location or size of the viewing zones
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/08—Series of lenses, lens blanks

Definitions

  • the invention relates to a system for treating Presbyopia. More particularly, the invention relates to a lens and a lens series that can be worn by a person to correct, or treat, symptoms of Presbyopia.
  • Presbyopia is a gradual loss of accommodation of the visual system of the human eye. This is due to an increase in the modulus of elasticity and growth of the crystalline lens of the eye that is located just behind the iris and the pupil. Tiny muscles in the eye called ciliary muscles pull and push the crystalline lens, thereby causing the curvature of the crystalline lens to adjust. This adjustment of the curvature of the crystalline lens results in an adjustment of the eye's focal power to bring objects into focus. As individuals age, the crystalline lens of the eye becomes less flexible and elastic, and, to a lesser extent, the ciliary muscles become less powerful. These changes result in inadequate adjustment of the lens of the eye (i.e., loss of accommodation) for various distances, which causes objects that are close to the eye to appear blurry.
  • Presbyopia In most people, the symptoms of Presbyopia begin to become noticeable under normal viewing conditions at around age 40, or shortly thereafter. However, Presbyopia actually begins to occur before the symptoms become noticeable and increases throughout a person's lifetime. In general, a person is deemed “symptomatic” when the residual accommodation is less than that required for one to read. Typical reading distance requires an accommodation ADD of 2.0 to 3.0 Diopters. Eventually, the residual accommodation is reduced to the point at which the individual becomes an absolute Presbyope after age 50. Symptoms of Presbyopia result in the inability to focus on objects close at hand. As the lens hardens, it is unable to focus the rays of light that come from nearby objects. People that are symptomatic typically have difficulty reading small print, such as that on computer display monitors, in telephone directories and newspaper advertisements, and may need to hold reading materials at arm's length.
  • Surgical systems include, for example, multifocal intraocular lenses (IOLs) and accommodation IOLs inserted into the eye and vision systems altered through corneal ablation techniques.
  • IOLs multifocal intraocular lenses
  • accommodation IOLs inserted into the eye and vision systems altered through corneal ablation techniques.
  • Bifocal contact lenses generally work well for patients who have a good tear film (i.e., moist eyes), good binocular vision (i.e., ability to focus both eyes together), good visual accuity (i.e., sharpness) in each eye, and no abnormalities or disease in the eyelids.
  • the bifocal contact lens wearer must invest the time required to maintain contact lenses, and generally should not be involved in occupations that impose high visual demands on the person.
  • bifocal contact lenses may limit binocular vision.
  • bifocal contact lenses are relatively expensive, in part due to the time it takes the patient to be accurately fitted.
  • An alternative to spectacles and bifocal contact lenses are monovision contact lenses.
  • monovision contact lenses one lens of the pair corrects for near vision and the other corrects for distance vision.
  • an emmetropic individual i.e., an individual who does not require distance vision correction
  • only a single contact lens is worn in one eye to correct for near vision.
  • one of the monovision contact lenses sets the focus of one eye, typically the dominate eye, at distance and the other lens adds a positive power bias to the other eye.
  • the magnitude of the positive power bias depends on the individual's residual accommodation and near vision requirements.
  • Individuals with low ADD requirements typically adapt very well to monovision contact lenses.
  • Advantages of monovision are patient acceptability, convenience, and lower cost. Disadvantages include headaches and fatigue experienced by the wearer during the adjustment period and decreases in visual accuity, which some people find unacceptable. As the ADD difference is increased, a loss of depth perception, night vision and intermediate vision limits its effectiveness of monovision systems.
  • Simultaneous vision multifocal contact lenses are also used to treat Presbyopia.
  • Types of multifocal contact lenses include, but are not limited to, center distance power designs, center near power designs, annular power designs, diffractive power designs, and the like.
  • Center near power designs are multifocal, or progressive, contact lenses used to treat Presbyopia. These lenses have a near vision zone in the center of the lens that extends outwardly a distance away from the center of the lens and a distance vision zone that is on the periphery of the lens and is concentric with and surrounds the near vision zone.
  • progressive contact lenses With more modern multifocal contact lenses, known as progressive contact lenses, the transition between the near and distance vision regions is more gradual than in earlier designs.
  • the ADD power is highest in the near vision region of the lens and lowest or zero in the distance vision region of the lens. In the transition region, the power continuously decreases from near vision ADD power to distance vision ADD power (or no ADD power) as the lens transitions from the near vision zone to the distance vision zone.
  • Multifocal lenses designed to treat symptoms of Presbyopia normally have relatively high ADD powers in the near vision zone of the lens to provide the correction needed for near vision.
  • the high ADD power in the near vision zone can result in visual artifacts, or ghost images, that affect the wearer's intermediate vision and can result in other problems that compromise the wearer's distance vision.
  • Presbyopic treatment systems Another shortcoming of current Presbyopic treatment systems is that most are ineffective at treating pre-Presbyopia, or emerging Presbyopia. Even prior to the symptoms of Presbyopia becoming readily noticeable to a person, that person may be experiencing pre-Presbyopia symptoms, such as inability of the vision system of the eye to accommodate in conditions of darkness or low lighting. Progressive multifocal lenses with very high near vision ADD powers are not suitable for use to treat pre-Presbyopia.
  • CooperVision, Inc. a company headquartered in Fairport, N.Y., recently began testing a contact lens that it claims is effective at treating pre-Presbyopia, but insufficient information is currently available about this product to verify that the lens is actually effective at treating pre-Presbyopia.
  • the invention provides a lens and a lens series for treating Presbyopia and pre-Presbyopia.
  • Each lens comprises a central optical zone, a peripheral optical zone and a transition zone.
  • the central optical zone has a power profile that provides an ADD power ranging from a maximum ADD power of between about 0 diopters and about 2.4 diopters and a minimum ADD power of between about 0 diopters and 0.2 diopters.
  • the peripheral optical zone has a power profile that provides an amount of negative spherical aberration between a semi-diameter of about 2 mm and a semi-diameter of about 3 mm.
  • the difference between the amount of negative spherical aberration provided at the inner semi-diameter of the peripheral optical zone and the amount of negative spherical aberration provided at the outer semi-diameter of the peripheral optical zone ranges from a minimum absolute value of about 0.65 diopters and a maximum absolute value of about 1.25 diopters.
  • the transition zone of the lens is interposed between and connected to the central optical zone and the peripheral optical zone and provides a transition between the central optical zone and the peripheral optical zone.
  • the transition zone has a power profile that is continuous.
  • the invention provides a method for designing a lens series for treating Presbyopia wherein each lens of the series has a power profile that provides the central optical zone with a selected amount of ADD power and that provides the peripheral optical zone with a selected amount of negative spherical aberration.
  • a transition zone is interposed between and connected to the central optical zone and the peripheral optical zone, and provides a transition between the central optical zone and the peripheral optical zone.
  • the power profiles for each lens are defined by the same mathematical function, except that the dc bias terms in the function for each lens of the series are different.
  • the invention provides a method for designing a lens for treating Presbyopia comprising selecting a power profile for a central optical zone of the lens, selecting a power profile for a peripheral optical zone of the lens, and selecting a power profile for a transition zone of the lens.
  • the power profile of the central optical zone is selected to provide an ADD power ranging from a maximum ADD power of between about 0 diopters and about 2.4 diopters and a minimum ADD power of between about 0 diopters and 0.2 diopters.
  • the peripheral optical zone has a power profile that provides an amount of negative spherical aberration between a semi-diameter of about 2 mm and a semi-diameter of about 3 mm.
  • the difference between the amount of negative spherical aberration provided at the inner semi-diameter of the peripheral optical zone and the amount of negative spherical aberration provided at the outer semi-diameter of the peripheral optical zone ranges from a minimum absolute value of about 0.65 diopters and a maximum absolute value of about 1.25 diopters.
  • the transition zone is interposed between and connected to the central optical zone and the peripheral optical zone and provides a transition between the central optical zone and the peripheral optical zone.
  • the power profile selected for the transition zone is continuous.
  • FIG. 1 illustrates a plan view of a contact lens in accordance with an illustrative embodiment of the invention.
  • FIG. 2 illustrates a plot of three different power profiles that represent examples of power profiles that are suitable for the lens shown in FIG. 1 .
  • FIG. 3 illustrates a plot of three different curves that represent the rates of change of the three profiles shown in FIG. 2 in diopters/mm across the central optical zone.
  • FIG. 4 illustrates a plot of a portion of the power profile in the peripheral optical zone shown in FIG. 1 extending from about 2.0 mm to about 3.0 mm from the center of the lens.
  • FIG. 5 illustrates a plot of a curve 81 that represents the rate of change of the profile shown in FIG. 4 in diopters/mm across the peripheral optical zone.
  • FIG. 6 illustrates two power profiles of two lenses of the same series that have different dc bias terms in accordance with an embodiment of the invention.
  • FIG. 7 illustrates a flowchart that represents the method of the invention in accordance with an illustrative embodiment for providing a lens series for treating Presbyopia.
  • the invention relates to a treatment system for treating Presbyopia and pre-Presbyopia that does not compromise the wearer's intermediate or distance vision.
  • Presbyopia and “pre-Presbyopia” will be referred to hereinafter as simply “Presbyopia”.
  • the invention is directed to a lens series comprising lenses that are tailored to provide an amount of positive ADD power in the central optical zone that is tuned to the residual accommodation and the dynamics of the individual's visual system and to provide an amount of negative spherical aberration in the peripheral optical zone. As an eye accommodates for a near vergence, the pupil constricts (myosis) and the spherical aberration of the optical system becomes more negative.
  • a lens series is defined herein as the range of ADD powers for a given ADD parameter.
  • a typical spherical lens series has ADD powers that range from ⁇ 10 diopters to +6 diopters in 0.25-diopter steps.
  • An ADD parameter is the aberration or dioptric power perturbation in the optical zone needed to increase the depth of focus by a target magnitude.
  • the magnitude and functional form of the perturbation of a given ADD parameter is targeted for a given magnitude of residual accommodation.
  • a particular ADD parameter is associated with all of the lenses in a particular lens series. Multiple ADD parameters are possible, and each ADD parameter targets a particular stage of Presbyopia.
  • FIG. 1 illustrates a plan view of a contact lens 1 in accordance with an illustrative embodiment of the invention.
  • a contact lens in accordance with the invention has at least a central optical zone 10 , a peripheral optical zone 20 , and a transition zone 30 that bridges the central optical zone 10 to the peripheral optical zone 20 .
  • the entire optical zone of a contact lens in accordance with the invention will be assumed to comprise the central optical zone 10 , the transition zone 30 and the peripheral optical zone 20 , although any of these zones may be made up of multiple zones.
  • the entire optical zone is about 7.0 to 8.0 millimeters (mm) in diameter.
  • the central optical zone ranges in diameter from about 2.0 to about 4.0 mm, and preferably is about 3.0 mm in diameter.
  • the peripheral optical zone 20 is an annulus surrounding the central optical zone 10 . Outside of the peripheral optical zone 20 is an outer peripheral region 25 that generally does not serve any optical purpose, but serves the purpose of fitting the anterior surface of the lens 1 to the surface of the eye.
  • the entire lens 1 including this outer peripheral region 25 is typically about 13.8 mm to about 14.60 mm in diameter.
  • FIG. 2 illustrates a plot of three different power profiles 40 , 50 and 60 that represent examples of power profiles that are suitable for the lens 1 shown in FIG. 1 .
  • the vertical axis in the plot represents optical power in diopters and the horizontal axis represents radius from the center of the lens outward in millimeters.
  • Presbyopia can be effectively treated by using a lens that provides an amount of positive ADD power in the central optical zone that is slightly less than that which is normally required for near vision accommodation if a selected magnitude of negative spherical aberration is provided by the peripheral optical zone.
  • a lens having this type of profile is effective at treating Presbyopia is that the selected magnitude of negative spherical aberration provided by the peripheral optical zone works in conjunction with the residual accommodation of the individual's eye to extend the eye's depth of focus, thereby improving near vision with minimally discernible blur for intermediate vision or distance vision. More specifically, the dynamic ocular factors of the eye work in conjunction with the positive ADD power provided by the central optical zone of the lens and with the effective ADD gained from the negative spherical aberration provided by the peripheral optical zone of the lens to induce a minimally discernible amount of blur that is tuned to maximize the individual's depth of focus.
  • the power profiles 40 , 50 and 60 each have a maximum ADD power in the central optical zone, i.e., at the intercepts of the curves on the vertical axis, and provide negative spherical aberration in the peripheral optical zone of the lens.
  • the maximum ADD power in the central optical zone for profile 40 is about 0.3 diopters
  • the maximum ADD power in the central optical zone for profile 50 is about 0.9 diopters
  • the maximum ADD power in the central optical zone for profile 60 is about 1.6 diopters.
  • the invention is not limited to these ADD powers.
  • the maximum ADD power typically ranges from about 0 diopters to about 2.4 diopters at the center of the central optical zone 10 .
  • the minimum ADD power typically ranges from about 0 diopters to about 0.2 diopters at the center of the central optical zone 10 .
  • the amplitudes (i.e., the dc bias component) and the functional forms of the ADD parameters that define the profiles are designed to work with individuals' residual accommodation to provide a smooth, constant visual acuity level through vergence.
  • the power profile that is selected for the wearer depends on the dynamic ocular factors of the wearer's eye.
  • a profile having a higher amplitude ADD in the central optical zone will bring the near point closer, but will result in both reduction in intermediate vision and more visual compromise through vergence. Therefore, the maximum ADD power of the central optical zone is selected based on the dynamic ocular factors of the eye so that the selected ADD power and the effective ADD gained from the negative spherical aberration provided by the peripheral optical zone of the lens induce a minimally discernible amount of blur tuned to maximize the individual's depth of focus.
  • the minimum ADD power in the central optical zone 10 occurs at the boundary of the central optical zone 10 and the transition zone 30 .
  • the distance from the lens center at which the central optical zone 10 ends and the transition zone 30 begins will vary depending on the lens design.
  • the central optical zone 10 typically has a diameter that ranges from about 2.0 to about 4.0 mm and preferably is about 3.0 mm. This corresponds to a radial distance from the lens center, i.e., a semi-diameter, of about 1.0 mm to about 2.0 mm.
  • the minimum ADD power of the central optical zone is selected based on the dynamic ocular factors of the eye so that the selected minimum ADD power and the effective ADD gained from the negative spherical aberration provided by the peripheral optical zone of the lens induce a minimally discernible amount of blur tuned to maximize the individual's depth of focus.
  • Negative spherical aberration means that light rays received through the peripheral region of the pupil are focused behind the retina while light rays received through the pupil center are focused on the retina.
  • a lens having the profile 40 is generally intended for a people experiencing symptoms of pre-Presbyopia, often referred to as emerging presbyopes.
  • the profile 40 has lower ADD powers than the ADD powers of profiles 50 and 60 .
  • an intermediate presbyope i.e., a person who has begun to experience symptoms of Presbyopia, which typically happens at around age 40
  • the residual accommodation of the eye is typically only slightly less than that required to focus clearly on objects that are close to the eye.
  • a lens having the profile 50 would be suitable because the ADD power is slightly greater than that provided by profile 40 in the central vision zone, but still less than that which would traditionally by used for these individuals.
  • a lens having profile 60 provides a higher ADD power across then entire central optical zone than that provided by profiles 40 and 50 , but still less ADD power than that traditionally used for lenses designed for these individuals.
  • FIG. 3 illustrates a plot of three different curves 41 , 51 and 61 that represent the rates of power change of the profiles 40 , 50 and 60 , respectively, shown in FIG. 2 in diopters/mm across the central optical zone 10 .
  • the rate of power change in the central optical zone should be appropriate for the eyes' residual accommodation. For optimal vision, the rate of power change over the central optical zone should be a smoothly varying function.
  • the rate of power change in the central optical zone typically has a minimum absolute value of about 0.15 diopters and a maximum absolute value of about 0.8 diopters at a semi-diameter of about 0.5 mm from the center of the lens.
  • the rate of power change in the central optical zone typically has a minimum absolute value of about 0.3 diopters and a maximum absolute value of about 2.0 diopters.
  • the corresponding rate of change 41 is constant (i.e., linear) across the central optical zone 10 . It can be seen that for profile 50 , the corresponding rate of change 51 increases in magnitude from the center of the lens out to a radius of about 1.0 mm, but then is generally constant from a radius of about 1.0 mm to a radius of about 1.45 mm. It can be seen that for profile 60 , the corresponding rate of change 61 increases from the center of the lens out to a radius of about 1.0 mm, and then decreases from a radius of about 1.0 mm out to a radius of about 1.45 mm.
  • the invention is not limited to the profiles shown in FIG. 2 .
  • Different mathematical functions and/or different ADD powers from those represented by profiles 40 , 50 and 60 can be used to define profiles that achieve the goals of the invention.
  • the mathematical functions that are used to define the power profiles are not limited to any particular type or class of mathematical function.
  • Each profile may be defined by a single mathematical function, such as a polynomial function, or it may be defined by a piece-wise function made up of multiple mathematical functions.
  • the profiles may also be defined by other functions, such as, for example, linear functions, spline functions (e.g., cubic splines and bicubic splines), Seidel functions, Zernike functions, conic functions and biconic functions.
  • the curves 51 and 61 shown in FIG. 3 are discontinuous at a radius of about 1.45 mm from the center of the central optical zone 10 .
  • the functions that represent the profiles 50 and 60 shown in FIG. 2 are continuous and therefore differentiable in the first derivative, the profiles 40 , 50 and 60 are suitable for lens designs for Presbyopia treatment. Because the profiles need not be differentiable in the second derivative, a wider variety of mathematical functions may be used to define the profiles, including piece-wise functions and splines.
  • the profile is continuous over the transition zone 30 to prevent vision from being affected by artifacts, also commonly referred to as ghosting.
  • Another way of stating that the profile is continuous over the transition zone 30 is to state that the profile is differentiable in at least the first derivative over the transition zone 30 .
  • the continuous changes in the rate curves 51 and 61 shown in FIG. 3 from the center of the central optical zone 10 almost to the transition zone 30 (1.5 mm from center) ensure that vision is not degraded by visual artifacts or ghost images.
  • FIG. 4 illustrates a plot of a portion of the power profile 80 in the peripheral optical zone 20 extending from about 2.0 mm to about 4.0 mm from the center of the lens 1 ( FIG. 1 ).
  • the power profile in the peripheral optical zone 20 provides an amount of negative spherical aberration.
  • the amount of negative spherical aberration will typically range from about ⁇ 0.1 to about ⁇ 0.7 diopters at the boundary of the peripheral optical zone 20 and the transition zone 30 to about ⁇ 2.0 diopters to about ⁇ 2.7 diopters at the boundary of the peripheral optical zone 20 and the outer peripheral region 25 .
  • this spherical aberration provides an amount of effective ADD that works in conjunction with the positive ADD provided by the central optical zone 10 and the ocular dynamics of the eye to induce a minimally discernible amount of blur tuned to maximize the individual's depth of focus.
  • FIG. 5 illustrates a plot of a curve 81 that represents the rate of power change of the profiles 40 , 50 and 60 in diopters/mm across the peripheral optical zone 20 .
  • the dashed lines 82 and 83 represent bounding functions that represent the typical power ranges across the peripheral optical zone 20 . It can be seen from FIG.
  • the rate of change across the peripheral optical zone 20 increases in magnitude in the direction away from the center of the lens and has a magnitude of about ⁇ 0.67 diopters/mm at a radius of about 2 mm and a magnitude of about ⁇ 1.00 diopters/mm at a radius of about 3 mm.
  • the rate of change has a magnitude of about ⁇ 1.33 diopters/mm at a radius of about 4 mm.
  • the rate of power change across the peripheral optical zone 20 ranges in magnitude from a magnitude of about ⁇ 0.5 diopters/mm at a radius of about 2 mm to a magnitude of about ⁇ 1.5 diopters/mm at a radius of about 3 mm at the boundary of the peripheral optical zone 20 and the transition zone 30 to a maximum absolute value of about 1.5 diopters at the boundary of the peripheral optical zone 20 and the outer peripheral region 25 .
  • the negative spherical aberration for a lens series preferably will be generally equal for all lenses of the series or will vary only by a small amount over the peripheral optical zone for different lenses of the series.
  • Providing the proper magnitude range of negative spherical aberration in the peripheral optical zone 20 increases depth of focus by providing a visually tolerable amount of image blur to extend depth of focus while taking into account the pupil dynamics of the visual system at vergence (myosis).
  • negative spherical aberration as that term is used herein, means that light rays received through the peripheral region of the pupil are focused behind the retina while light rays received through the pupil center are focused on the retina. Equivalently stated, the periphery of the pupil has less power than the center of the pupil.
  • SA spherical aberration
  • spherical aberration in the peripheral optical zone will be equal.
  • the peripheral optical zone 20 may be described by Zernike polynomials, aspheric terms, or the equivalent.
  • the power profile in the peripheral optical zone 20 may be described by a quadratic or a perturbed quadratic power function.
  • each lens will have a power profile defined the same ADD parameter, but the dc bias term will be different for each lens of the series.
  • FIG. 6 illustrates two power profiles 90 and 91 of two lenses of the same series that have different dc bias terms in accordance with an embodiment of the invention.
  • the dc bias term corresponds to the location at which the profile intersects the Y-axis. This value is obtained by setting all of the X-axis terms of the function equal to zero such that the value of the function corresponds to the dc bias term, i.e., the constant in the equation.
  • over-plusing the near eye by a small magnitude will sometimes result in an improvement in the treatment of Presbyopia.
  • over-plusing the near eye by a small amount increases depth of focus.
  • the term “over-plusing” as that term is used herein means fitting an eye with a lens having a profile defined by the same ADD parameter as another lens of the series used for the other eye, but that also has a greater dc bias term than the other lens of the series. For example, with reference to FIG. 6 , the near eye would be fitted with a lens having profile 91 whereas the distance eye would be fitted with a lens having the profile 90 .
  • the invention has been described above with reference to contact lenses, the invention applies equally to phakic or aphakic lenses, as well as to optical power profiles created by performing corneal ablation.
  • the invention has been described with reference to the simultaneous vision lens shown in FIG. 1 , lenses in accordance with the invention may also be used for modified monovision since the power profiles described herein reduce the disparity between distance and near powers.
  • FIG. 7 illustrates a flowchart that represents the method of the invention in accordance with an illustrative embodiment for providing a lens series for treating Presbyopia.
  • a lens series is provided such that each lens of the series has a power profile that provides ADD power in the central optical zone and negative spherical aberration in the peripheral optical zone, as indicated by block 101 .
  • the maximum ADD power preferably occurs at the center of the central optical zone 10 ( FIG. 1 ) and the minimum ADD power preferably occurs at the boundary between the central optical zone 10 and the transition zone 30 .
  • the respective power profile is provided with different dc bias term, as indicated by block 102 .
  • Each lens of the lens series has a power profile in the transition region that preferably is continuous, as indicated by block 103 , which means that the profile in the transition region is differentiable in at least the first derivative, but not necessarily in the second or higher derivatives.

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Mathematical Physics (AREA)
  • Eyeglasses (AREA)
  • Prostheses (AREA)
US12/229,125 2007-08-22 2008-08-20 Presbyopic treatment system Abandoned US20090051870A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12/229,125 US20090051870A1 (en) 2007-08-22 2008-08-20 Presbyopic treatment system
US13/162,182 US8672474B2 (en) 2007-08-22 2011-06-16 Presbyopic treatment system
US14/167,648 US9039172B2 (en) 2007-08-22 2014-01-29 Presbyopic treatment system
US14/693,303 US9557579B2 (en) 2007-08-22 2015-04-22 Presbyopic treatment system
US15/385,992 US20170102556A1 (en) 2007-08-22 2016-12-21 Presbyopic treatment system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95718307P 2007-08-22 2007-08-22
US12521508P 2008-04-23 2008-04-23
US12/229,125 US20090051870A1 (en) 2007-08-22 2008-08-20 Presbyopic treatment system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/162,182 Continuation US8672474B2 (en) 2007-08-22 2011-06-16 Presbyopic treatment system

Publications (1)

Publication Number Publication Date
US20090051870A1 true US20090051870A1 (en) 2009-02-26

Family

ID=40032824

Family Applications (5)

Application Number Title Priority Date Filing Date
US12/229,125 Abandoned US20090051870A1 (en) 2007-08-22 2008-08-20 Presbyopic treatment system
US13/162,182 Active 2028-09-01 US8672474B2 (en) 2007-08-22 2011-06-16 Presbyopic treatment system
US14/167,648 Active US9039172B2 (en) 2007-08-22 2014-01-29 Presbyopic treatment system
US14/693,303 Active US9557579B2 (en) 2007-08-22 2015-04-22 Presbyopic treatment system
US15/385,992 Abandoned US20170102556A1 (en) 2007-08-22 2016-12-21 Presbyopic treatment system

Family Applications After (4)

Application Number Title Priority Date Filing Date
US13/162,182 Active 2028-09-01 US8672474B2 (en) 2007-08-22 2011-06-16 Presbyopic treatment system
US14/167,648 Active US9039172B2 (en) 2007-08-22 2014-01-29 Presbyopic treatment system
US14/693,303 Active US9557579B2 (en) 2007-08-22 2015-04-22 Presbyopic treatment system
US15/385,992 Abandoned US20170102556A1 (en) 2007-08-22 2016-12-21 Presbyopic treatment system

Country Status (15)

Country Link
US (5) US20090051870A1 (de)
EP (3) EP2183639A1 (de)
JP (2) JP5966245B2 (de)
KR (2) KR101790464B1 (de)
CN (2) CN102722037B (de)
AR (1) AR067986A1 (de)
AU (1) AU2008289500A1 (de)
BR (1) BRPI0814307B1 (de)
CA (1) CA2692829C (de)
MX (1) MX2010002006A (de)
RU (2) RU2471212C2 (de)
SG (1) SG183746A1 (de)
TW (1) TWI487516B (de)
WO (1) WO2009025808A1 (de)
ZA (1) ZA200908799B (de)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013114215A1 (en) 2012-02-03 2013-08-08 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
WO2013114209A2 (en) 2012-02-03 2013-08-08 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
WO2013114206A1 (en) 2012-02-03 2013-08-08 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
WO2013114208A1 (en) 2012-02-03 2013-08-08 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
US20160062143A1 (en) * 2014-08-29 2016-03-03 Johnson & Johnson Vision Care, Inc. Multifocal lens design and method for preventing and/or slowing myopia progression
US20160161763A1 (en) * 2013-08-01 2016-06-09 Menicon Co., Ltd. Presbyopia contact lens set
JP2017219835A (ja) * 2016-06-07 2017-12-14 九揚貿易有限公司 コンタクトレンズ
US10028825B2 (en) 2016-02-09 2018-07-24 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture
US20210228337A1 (en) * 2015-04-14 2021-07-29 Z Optics, Inc. High definition and extended depth of field intraocular lens
US11452595B2 (en) 2007-08-27 2022-09-27 Amo Groningen B.V. Multizonal lens with enhanced performance
US11506914B2 (en) 2010-12-01 2022-11-22 Amo Groningen B.V. Multifocal lens having an optical add power progression, and a system and method of providing same
US11886046B2 (en) 2019-12-30 2024-01-30 Amo Groningen B.V. Multi-region refractive lenses for vision treatment
US12121433B2 (en) 2020-07-07 2024-10-22 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI487516B (zh) * 2007-08-22 2015-06-11 Novartis Ag 老花眼的治療系統
CA2771825C (en) * 2009-09-01 2018-08-21 Arthur Bradley Multifocal correction providing improved quality of vision
US8992012B2 (en) * 2011-06-23 2015-03-31 Johnson & Johnson Vision Care, Inc. Lens systems for presbyopia
TWI588560B (zh) 2012-04-05 2017-06-21 布萊恩荷登視覺協會 用於屈光不正之鏡片、裝置、方法及系統
TWI480622B (zh) * 2012-04-26 2015-04-11 Jau Cyen Spectacles Co Ltd 非球面超薄遠視鏡片
US9201250B2 (en) 2012-10-17 2015-12-01 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
US9541773B2 (en) 2012-10-17 2017-01-10 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
TWI626491B (zh) 2012-12-10 2018-06-11 布萊恩荷登視覺協會 用於視力校正之具有一或多個多正焦區域之眼用光學透鏡
US9231131B2 (en) 2014-01-07 2016-01-05 International Business Machines Corporation Integrated photodetector waveguide structure with alignment tolerance
CN111265331B (zh) 2014-09-09 2022-09-09 斯塔尔外科有限公司 具有扩展的景深和增强的远距视力的眼科植入物
KR102017316B1 (ko) * 2015-02-02 2019-09-02 노바르티스 아게 안질환의 신체역학적 진단용 광학 기구
CN106526888B (zh) 2015-09-15 2019-08-06 星欧光学股份有限公司 隐形眼镜产品
US11567346B2 (en) 2016-02-10 2023-01-31 Visioneering Technologies, Inc. Induced aperture lens and method
JP6953423B2 (ja) 2016-03-09 2021-10-27 スター サージカル カンパニー 被写界深度延長及び遠見視力向上を伴う眼科インプラント
WO2017213232A1 (ja) * 2016-06-09 2017-12-14 参天製薬株式会社 単焦点眼内レンズ
US10048512B2 (en) * 2016-10-08 2018-08-14 eyeBrain, Medical, Inc. Low-convergence spectacles
US9933633B1 (en) 2016-11-08 2018-04-03 Paul Douglas Becherer Bifocal contact lenses providing reduced glare and blurriness in dim lighting
TWI636296B (zh) * 2017-08-28 2018-09-21 精華光學股份有限公司 視力矯正用光學鏡片
KR102560250B1 (ko) 2018-08-17 2023-07-27 스타 서지컬 컴퍼니 나노 구배의 굴절률을 나타내는 중합체 조성물
WO2020236330A1 (en) * 2019-05-20 2020-11-26 Junzhong Liang Methods and devices for wavefront treatments of astigmatism, coma, presbyopia in human eyes
EP4018254A4 (de) * 2019-08-23 2023-12-27 Brien Holden Vision Institute Limited Ophthalmische linsen zur verringerung, minimierung und/oder beseitigung von interferenzen bei scharfen bildern durch unscharfes licht
CN114911072A (zh) * 2021-02-09 2022-08-16 晶硕光学股份有限公司 智能多焦点镜片及多焦点散光镜片
CN114911071B (zh) * 2021-02-10 2023-10-20 菲特兰有限公司 用于预防近视或延缓近视发展的眼科镜片
CN114010371A (zh) * 2021-10-25 2022-02-08 天津世纪康泰生物医学工程有限公司 一种后房型有晶体眼渐进多焦点人工晶状体

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5754270A (en) * 1996-11-08 1998-05-19 Unilens Corp., Usa Multifocal lens utilizing rapid power shift transition zone
US5815239A (en) * 1996-12-05 1998-09-29 Chapman; Judith E. Contact lenses providing improved visual acuity
US6030077A (en) * 1998-03-11 2000-02-29 Menicon Co., Ltd. Multifocal ocular lens having intermediate region with continuously varying optical power
US6244708B1 (en) * 1998-09-28 2001-06-12 Bausch & Lomb Incorporated Contact lenses providing improved visual acuity
US6457826B1 (en) * 1998-08-06 2002-10-01 John B. W. Lett Multifocal aspheric lens
US6474814B1 (en) * 2000-09-08 2002-11-05 Florida Optical Engineering, Inc Multifocal ophthalmic lens with induced aperture
US6554425B1 (en) * 2000-10-17 2003-04-29 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses for high order aberration correction and processes for production of the lenses
US20040021824A1 (en) * 2002-07-31 2004-02-05 Ming Ye Toric multifocal contact lenses
US20050041203A1 (en) * 2003-08-20 2005-02-24 Lindacher Joseph Michael Ophthalmic lens with optimal power profile
US20050099595A1 (en) * 2003-11-12 2005-05-12 Lindacher Joseph M. Translating bifocal wear modality
US6899425B2 (en) * 2003-10-28 2005-05-31 Johnson & Johnson Vision Care, Inc. Multifocal ophthalmic lenses
US20060170861A1 (en) * 2004-12-22 2006-08-03 Lindacher Joseph M Contact lens design for large amplitude translation
US7101041B2 (en) * 2004-04-01 2006-09-05 Novartis Ag Contact lenses for correcting severe spherical aberration
US20080212022A1 (en) * 2004-11-22 2008-09-04 Novartis Ag Series of aspherical contact lenses
US20080291393A1 (en) * 2007-05-21 2008-11-27 Menezes Edgar V Ophthalmic lenses for prevention of myopia progression

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195919A (en) 1977-10-31 1980-04-01 Shelton William A Contact lens with reduced spherical aberration for aphakic eyes
US5225858A (en) 1987-06-01 1993-07-06 Valdemar Portney Multifocal ophthalmic lens
US5771088A (en) 1993-03-27 1998-06-23 Pilkington Barnes Hind, Inc. Contact lens designed to accommodate and correct for the effects of presbyopia
US5684560A (en) * 1995-05-04 1997-11-04 Johnson & Johnson Vision Products, Inc. Concentric ring single vision lens designs
US5864379A (en) * 1996-09-27 1999-01-26 Dunn; Stephen A. Contact lens and process for fitting
US5812236A (en) * 1996-11-15 1998-09-22 Permeable Technologies, Inc. Multifocal corneal contact lens pair
JP3683093B2 (ja) * 1998-03-11 2005-08-17 株式会社メニコン 多焦点型コンタクトレンズ
US6260966B1 (en) * 1998-03-11 2001-07-17 Menicon Co. Ltd. Multifocal ocular lens
US6086203A (en) * 1998-09-03 2000-07-11 Johnson & Johnson Vision Care, Inc. Progressive addition lenses
US6149271A (en) * 1998-10-23 2000-11-21 Innotech, Inc. Progressive addition lenses
US6176580B1 (en) * 1999-04-02 2001-01-23 Johnson & Johnson Vision Care, Inc. Method of designing and fitting contact lenses taking into account material properties of the lenses
AU1659301A (en) 1999-11-19 2001-05-30 Wesley-Jessen Corporation Multifocal aspheric lens
AUPR276601A0 (en) * 2001-01-31 2001-02-22 Newman, Steve A contact lens for refractive correction and capable of engagement with an eye either inside out or right way out
US20030117577A1 (en) * 2001-12-20 2003-06-26 Jones Larry G. Multifocal ophthalmic lenses
JP3860041B2 (ja) 2002-01-23 2006-12-20 株式会社メニコン コンタクトレンズおよびコンタクトレンズの設計方法
US6802606B2 (en) * 2003-02-04 2004-10-12 Johnson & Johnson Vision Care, Inc. Multifocal contact lens pairs
TWI487516B (zh) * 2007-08-22 2015-06-11 Novartis Ag 老花眼的治療系統

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5754270A (en) * 1996-11-08 1998-05-19 Unilens Corp., Usa Multifocal lens utilizing rapid power shift transition zone
US5815239A (en) * 1996-12-05 1998-09-29 Chapman; Judith E. Contact lenses providing improved visual acuity
US6030077A (en) * 1998-03-11 2000-02-29 Menicon Co., Ltd. Multifocal ocular lens having intermediate region with continuously varying optical power
US6457826B1 (en) * 1998-08-06 2002-10-01 John B. W. Lett Multifocal aspheric lens
US6244708B1 (en) * 1998-09-28 2001-06-12 Bausch & Lomb Incorporated Contact lenses providing improved visual acuity
US6474814B1 (en) * 2000-09-08 2002-11-05 Florida Optical Engineering, Inc Multifocal ophthalmic lens with induced aperture
US6554425B1 (en) * 2000-10-17 2003-04-29 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses for high order aberration correction and processes for production of the lenses
US20040021824A1 (en) * 2002-07-31 2004-02-05 Ming Ye Toric multifocal contact lenses
US20050041203A1 (en) * 2003-08-20 2005-02-24 Lindacher Joseph Michael Ophthalmic lens with optimal power profile
US6899425B2 (en) * 2003-10-28 2005-05-31 Johnson & Johnson Vision Care, Inc. Multifocal ophthalmic lenses
US20050099595A1 (en) * 2003-11-12 2005-05-12 Lindacher Joseph M. Translating bifocal wear modality
US7101041B2 (en) * 2004-04-01 2006-09-05 Novartis Ag Contact lenses for correcting severe spherical aberration
US20080212022A1 (en) * 2004-11-22 2008-09-04 Novartis Ag Series of aspherical contact lenses
US20060170861A1 (en) * 2004-12-22 2006-08-03 Lindacher Joseph M Contact lens design for large amplitude translation
US20080291393A1 (en) * 2007-05-21 2008-11-27 Menezes Edgar V Ophthalmic lenses for prevention of myopia progression

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11452595B2 (en) 2007-08-27 2022-09-27 Amo Groningen B.V. Multizonal lens with enhanced performance
US11506914B2 (en) 2010-12-01 2022-11-22 Amo Groningen B.V. Multifocal lens having an optical add power progression, and a system and method of providing same
WO2013114215A1 (en) 2012-02-03 2013-08-08 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
WO2013114209A2 (en) 2012-02-03 2013-08-08 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
WO2013114206A1 (en) 2012-02-03 2013-08-08 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
WO2013114208A1 (en) 2012-02-03 2013-08-08 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
US8777415B2 (en) 2012-02-03 2014-07-15 Coopervision International Holding Company, L.P. Multifocal contact lenses and related methods and uses to improve vision of prebyopic subjects
US8876286B2 (en) 2012-02-03 2014-11-04 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
US8882265B2 (en) 2012-02-03 2014-11-11 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
US8894202B2 (en) 2012-02-03 2014-11-25 Coopervision International Holding Company, Lp Multifocal contact lenses and related methods and uses to improve vision of presbyopic subjects
US9952449B2 (en) * 2013-08-01 2018-04-24 Menicon Co., Ltd. Presbyopia contact lens set
US20160161763A1 (en) * 2013-08-01 2016-06-09 Menicon Co., Ltd. Presbyopia contact lens set
EP3032320A4 (de) * 2013-08-01 2017-03-22 Menicon Co., Ltd. Presbyopiekontaktlinse
US10061143B2 (en) * 2014-08-29 2018-08-28 Johnson & Johnson Vision Care, Inc. Multifocal lens design for preventing and/or slowing myopia progression
US20160062143A1 (en) * 2014-08-29 2016-03-03 Johnson & Johnson Vision Care, Inc. Multifocal lens design and method for preventing and/or slowing myopia progression
US20210228337A1 (en) * 2015-04-14 2021-07-29 Z Optics, Inc. High definition and extended depth of field intraocular lens
US11696823B2 (en) 2015-04-14 2023-07-11 Z Optics, Inc. High definition and extended depth of field intraocular lens
US10426601B2 (en) 2016-02-09 2019-10-01 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture
US10624735B2 (en) 2016-02-09 2020-04-21 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture
US10709550B2 (en) 2016-02-09 2020-07-14 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture
US11116624B2 (en) 2016-02-09 2021-09-14 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture
US10028825B2 (en) 2016-02-09 2018-07-24 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture
JP2017219835A (ja) * 2016-06-07 2017-12-14 九揚貿易有限公司 コンタクトレンズ
US11886046B2 (en) 2019-12-30 2024-01-30 Amo Groningen B.V. Multi-region refractive lenses for vision treatment
US12121433B2 (en) 2020-07-07 2024-10-22 Amo Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture

Also Published As

Publication number Publication date
KR101790464B1 (ko) 2017-10-25
AR067986A1 (es) 2009-10-28
CN101784943B (zh) 2012-08-08
CN102722037A (zh) 2012-10-10
CN101784943A (zh) 2010-07-21
RU2471212C2 (ru) 2012-12-27
SG183746A1 (en) 2012-09-27
US9039172B2 (en) 2015-05-26
JP2014222360A (ja) 2014-11-27
US20150226981A1 (en) 2015-08-13
WO2009025808A1 (en) 2009-02-26
MX2010002006A (es) 2010-03-10
CA2692829C (en) 2017-01-03
KR20160141866A (ko) 2016-12-09
RU2522885C2 (ru) 2014-07-20
JP5966245B2 (ja) 2016-08-10
BRPI0814307B1 (pt) 2018-12-04
EP2610666B1 (de) 2019-09-25
US8672474B2 (en) 2014-03-18
EP2597508A1 (de) 2013-05-29
RU2012137148A (ru) 2014-03-10
US9557579B2 (en) 2017-01-31
US20140146284A1 (en) 2014-05-29
CA2692829A1 (en) 2009-02-26
RU2010110635A (ru) 2011-09-27
KR20100056536A (ko) 2010-05-27
JP2010537247A (ja) 2010-12-02
AU2008289500A1 (en) 2009-02-26
TW200916080A (en) 2009-04-16
ZA200908799B (en) 2011-02-23
CN102722037B (zh) 2015-03-11
BRPI0814307A2 (pt) 2015-02-03
EP2610666A1 (de) 2013-07-03
KR101702136B1 (ko) 2017-02-03
JP6069795B2 (ja) 2017-02-01
US20110310347A1 (en) 2011-12-22
TWI487516B (zh) 2015-06-11
EP2183639A1 (de) 2010-05-12
US20170102556A1 (en) 2017-04-13

Similar Documents

Publication Publication Date Title
US9557579B2 (en) Presbyopic treatment system
US10969608B2 (en) Contact lenses for myopic eyes and methods of treating myopia
US8894203B2 (en) Multifocal correction providing improved quality of vision
AU2012244130B2 (en) Presbyopic treatment system
US20240210731A1 (en) Enhanced-summation contact lens pair for correction of presbyopia, and related lenses pair systems and fitting methods

Legal Events

Date Code Title Description
AS Assignment

Owner name: NOVARTIS AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LINDACHER, JOSEPH MICHAEL;SASTRY, SHYAMANT RAMANA;REEL/FRAME:021567/0710

Effective date: 20080728

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE